Vanda Pharmaceuticals Inc. (VNDA) is a publicly traded Healthcare sector company. As of July 8, 2026, VNDA trades at $6.44 with a market cap of $374.64M and a P/E ratio of -1.55. VNDA moved +2.57% today. Year to date, VNDA is -9.10%; over the trailing twelve months it is +30.67%. Its 52-week range spans $3.81 to $9.94. Analyst consensus is buy with an average price target of $19.50. Rallies surfaces VNDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks VNDA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $6.44 |
| Market Cap | $374.64M |
| P/E Ratio | -1.55 |
| EPS | $-4.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.94 |
| 52-Week Low | $3.81 |
| Volume | 432.53K |
| Avg Volume | 0 |
| Revenue (TTM) | $217.78M |
| Net Income | $-239.55M |
| Gross Margin | 0.00% |
2 analysts cover VNDA: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $19.50.